...
首页> 外文期刊>The Lancet >Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.
【24h】

Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.

机译:一项低血清促甲状腺激素结果可预测老年人的全因和心血管死亡率:一项为期10年的队列研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Low serum thyrotropin, in combination with normal concentrations of circulating thyroid hormones, is common, especially in elderly people and in individuals with a history of thyroid disease. We aimed to assess the long-term effects of subclinical hyperthyroidism on mortality. METHODS: We did a population-based study of mortality in a cohort of 1191 individuals not on thyroxine or antithyroid medication. All participants were aged 60 years or older. We measured concentration of thyrotropin in serum at baseline in 1988-89. We recorded vital status on June 1, 1999, and ascertained causes of death for those who had died. We compared data for causes of death with age-specific, sex-specific, and year-specific data for England and Wales. We also compared mortality within the cohort according to initial thyrotropin measurement. RESULTS: During 9733 person-years of follow-up, 509 of 1191 people died, the expected number of deaths being 496 (standardised mortality ratio [SMR] 1.0, 95% CI 0.9-1.1). Mortality from all causes was significantly increased at 2 (SMR 2.1), 3 (2.1), 4 (1.7), and 5 (1.8) years after first measurement in those with low serum thyrotropin (n471). These increases were largely accounted for by significant increases in mortality due to circulatory diseases (SMR 2.1, 2.2, 1.9, 2.0, at years 2, 3, 4, and 5 respectively). Increases in mortality from all causes in years 2-5 were higher in patients with low serum thyrotropin than in the rest of the cohort (hazard ratios for years 2, 3, 4, and 5 were 2.1, 2.2, 1.8, and 1.8, respectively). This result reflects an increase in mortality from circulatory diseases (hazard ratios at years 2, 3, 4, and 5 were 2.3, 2.6, 2.3, 2.3), and specifically from cardiovascular diseases (hazard ratios at years 2, 3, 4, and 5 were 3.3, 3.0, 2.3, 2.2). INTERPRETATION: A single measurement of low serum thyrotropin in individuals aged 60 years or older is associated with increased mortality from all causes, and in particular mortality due to circulatory and cardiovascular diseases.
机译:背景:低血清促甲状腺激素结合正常浓度的循环甲状腺激素很常见,尤其是在老年人和有甲状腺疾病史的人中。我们旨在评估亚临床甲状腺功能亢进症对死亡率的长期影响。方法:我们对1191例未使用甲状腺素或抗甲状腺药物的患者进行了基于人群的死亡率研究。所有参与者年龄均在60岁以上。我们在1988-89年基线时测量了血清中促甲状腺激素的浓度。我们于1999年6月1日记录了生命状况,并确定了死者的死亡原因。我们将死亡原因的数据与英格兰和威尔士的年龄,性别和年份的数据进行了比较。我们还根据最初的促甲状腺激素测量结果比较了该队列中的死亡率。结果:在9733人-年的随访中,1191人中有509人死亡,预期死亡人数为496(标准死亡率[SMR] 1.0,95%CI 0.9-1.1)。血清促甲状腺激素水平低的患者(n471)在首次测量后第2年(SMR 2.1),3(2.1),4(1.7)和5(1.8)年,所有原因的死亡率均显着增加。这些增加的主要原因是由于循环系统疾病导致的死亡率显着增加(分别在第2、3、4和5年分别达到SMR 2.1、2.2、1.9、2.0)。血清促甲状腺激素水平低的患者在2-5岁期间因各种原因导致的死亡率增加高于其余人群(2、3、4和5年的危险比分别为2.1、2.2、1.8和1.8 )。该结果反映出循环系统疾病(第2、3、4和5年的危险比为2.3、2.6、2.3、2.3),特别是心血管疾病(第2、3、4和4年的危险比)的死亡率增加。 5个分别是3.3、3.0、2.3、2.2)。解释:对60岁或60岁以上的老年人进行一次血清低水平促甲状腺激素的测定,会导致各种原因引起的死亡率增加,尤其是循环系统和心血管疾病引起的死亡率增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号